AKT1 and acute myeloid leukemia: Some current studies have also shown that CDA has high efficacy in treating acute myeloid leukemia, mainly through the PI3K/Akt pathway, which regulates apoptosis and thus influences the disease’s pathological process (Wei et al., 2018).